CLOVIS ONCOLOGY Forum: Community User: Maroni

In diversen Foren wird über ein Buy-Out spekuliert ..... Hmm

Bleibt die Frage, warum er jetzt über 5% hält, und seit wann?

Morgan Stanley owns 1,697,692 shares or 5.2%: 13G filed by Morgan Stanleyhttps://t.co/FDMoNz1mt3,https://t.co/uXklE7bINS

Schlechter Tag.....

@ACInvestorBlog $CLVS CMF is now positive.....buying momentum is starting to rise, a breakout could be possible.https://t.co/JwxWQSVgUO

Kazazian Asset Management LLC purchased a new stake in Clovis Oncology Inc. (NASDAQ:CLVS) during the first quarter, Holdings Channel reports. The fund purchased 14,666 shares of the biopharmaceutical company’s stock, valued at approximately $282,000. Clovis Oncology comprises 0.5% of Kazazian Asset Management LLC’s portfolio, making the stock its 24th largest position. Several other hedge funds have also recently modified their holdings of the company. State Street Corp boosted its stake in shares of Clovis Oncology by 21.2% in the first quarter. State Street Corp now owns 1,797,874 shares of the biopharmaceutical company’s stock valued at $34,525,000 after buying an additional 313,893 shares during the last quarter. Redmile Group LLC boosted its stake in shares of Clovis Oncology by 87.5% in the fourth quarter. Redmile Group LLC now owns 1,795,936 shares of the biopharmaceutical company’s stock valued at $62,858,000 after buying an additional 838,302 shares during the last quarter. HealthCor Management L.P. purchased a new stake in shares of Clovis Oncology during the fourth quarter valued at approximately $53,375,000. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Clovis Oncology by 7.1% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 825,085 shares of the biopharmaceutical company’s stock valued at $15,842,000 after buying an additional 54,476 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in shares of Clovis Oncology during the first quarter valued at approximately $9,896,000. Shares of Clovis Oncology Inc. (NASDAQ:CLVS) traded down 0.07% during midday trading on Monday, hitting $14.72. The stock had a trading volume of 66,652 shares. Clovis Oncology Inc. has a 52 week low of $11.57 and a 52 week high of $116.75. The stock has a 50-day moving average of $14.76 and a 200 day moving average of $18.53. The stock’s market cap is $565.03 million.

http://tinyurl.com/jrexno8

http://tinyurl.com/hcgbyj7

Clovis Oncology Inc (NASDAQ:CLVS) price action is coiling up here in anticipation of a breakout w/ directional conviction. I have highlighted a potential ascending triangle pattern, which if confirmed would project a target around $17. Also take note that on the daily time-frame the MACD has been moving up and the RSI is in the bullish zone, indicating bullishness. CLVS will move very quickly, so keep a very close eye on the stock. 

Hoffentlich!

jetzt vlt?;)..glaube es geht langsam in die richtige Richtung

Echt Shit...

Gewinne wieder weg

schön gedreht bei 11.8-12

Oh man.. Schade heute..

immer noch knapp 16.8....